Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia

NCT06184009 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

370

Enrollment

OTHER

Sponsor class

Conditions

Pediatric Acute Lymphoblastic Leukemia

Interventions

DRUG: ALL, High risk

Sponsor

Jae Wook Lee

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]